Solid Biosciences (SLDB) Appoints Dr. Martin Freed to Board
Tweet Send to a Friend
Solid Biosciences Inc. (NASDAQ: SLDB) today announced that Martin Freed, M.D., F.A.C.P., a biopharmaceutical expert with more than 25 years ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


